Results
psychiatric illness, psychiatric
A total of 35 patients participated in the study: twelve women and 23 men. The NLR was available for all the women and 22 men. Eleven women and 22 men took part in the neuropsychological testing. Demographic and baseline anthropometric data (sex, age, education, years of psychiatric illness, number of previous psychiatric hospitalizations, and body mass index) are described below (Table 
Group comparison between sexes on demographic and clinical data, using the two-tailed Welch t-test (Mean ± SD for parametric data; Median (First quartile; Third quartile) for non-parametric data)* Statistically significant (p < 0.05)Female patients had a significantly higher NLR than male patients (Fig. 
NLR and PLR in Each Sex and their Relationship to Antipsychotic Dose and Working Memory in Women. Among women, there were significant correlations between the daily antipsychotic dose (in CPZ units) and several cognitive indicators (Table 
Correlation between Neuropsychological Tests and Antipsychotic Dose in Women. Correlation between neuropsychological tests (Digit Span task, Animal Verbal Fluency test, time taken in the Trail Making B test, and time and errors in the Stroop Colors test) and antipsychotic dose in CPZ units of females (n = 11)
Correlation between neuropsychological tests and antipsychotic dose (CPZ units) in females* Statistically significant (p < 0.05)There were no further significant correlations between antipsychotic dose, NLR or PLR and other cognitive tests in women – i.e., the Corsi Block test, the COWA (FAS) test, the Rey series of tests, and other measurements and varieties of the Trail Making and Stroop tests (Table 
Group comparison between sexes on neuropsychological tests, using the two-tailed Welch t-test (Mean ± SD).* Statistically significant (p < 0.05)